Beyond Tumor Necrosis Factor (TNF) - Inhibitors: Optimizing Care for Patients with Inflammatory bowel disease (IBD) is organized by Gastrointestinal Health Foundation (GiHF) and will be held from Nov 27, 2018 - Nov 27, 2019. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits™.

Target Audience:
This enduring activity has been designed to meet the educational needs of gastroenterologists and gastroenterology fellows, nurse practitioners, physician assistants, and all other healthcare professionals involved in the care and treatment of adult patients with IBD.

Educational Objectives:
After completing this program, participants should be better able to:
• Describe the mechanism, efficacy, and safety of new and emerging therapies in IBD
• Incorporate practice guidelines/pathways and newer therapies effectively into clinical practice
• Summarize clinical practice guidelines for health maintenance strategies, including immunization recommendations, for patients with IBD

Additional details will be posted as soon as they are available.

Intended Audience

Biotechnology, Gastroenterology

Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


Gastrointestinal Health Foundation (GiHF)

View Organizer Details


(732) 381-8887